inter-assay accuracy (Prevalere Life Sciences Inc)
90
Structured Review
Prevalere Life Sciences Inc
inter-assay accuracy
Inter Assay Accuracy, supplied by Prevalere Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inter-assay+accuracy/inter+assay+accuracy/pm19385712-73-1-14
Average 90 stars, based on 1 article reviews
Inter Assay Accuracy, supplied by Prevalere Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inter-assay+accuracy/inter+assay+accuracy/pm19385712-73-1-14
Average 90 stars, based on 1 article reviews
inter-assay accuracy - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Inter Assay:Article Title: Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation. Article Snippet: Objectives: The objectives of this analysis were to characterize the pharmacokinetics of duloxetine at steady state in patients, estimate the variability, identify significant covariates that may influence duloxetine pharmacokinetics and provide appropriate dosing recommendations for patients on duloxetine treatment.. Methods: The pharmacokinetic meta-analysis dataset was created from one open-label clinical study and four double-blind, placebo-controlled clinical studies.. Duloxetine concentrations (N = 2002) were obtained from 594 patients diagnosed with major depressive disorder (n = 223), diabetic peripheral neuropathic pain (n = 112), stress urinary incontinence (n= 128) and fibromyalgia (n = 131). Biomarker Discovery:Article Title: Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation. Article Snippet: Objectives: The objectives of this analysis were to characterize the pharmacokinetics of duloxetine at steady state in patients, estimate the variability, identify significant covariates that may influence duloxetine pharmacokinetics and provide appropriate dosing recommendations for patients on duloxetine treatment.. Methods: The pharmacokinetic meta-analysis dataset was created from one open-label clinical study and four double-blind, placebo-controlled clinical studies.. Duloxetine concentrations (N = 2002) were obtained from 594 patients diagnosed with major depressive disorder (n = 223), diabetic peripheral neuropathic pain (n = 112), stress urinary incontinence (n= 128) and fibromyalgia (n = 131). |